Apply real world data to your trial with nonidentified data from more than 500 million patients across eight countries using pre-built analytics.
Real world data (RWD) and real world evidence (RWE) are playing an increasing role in health care decisions, with the 21st Century Cures Act, placing additional focus on the use of these types of data to support regulatory decision making. As a result, pharma companies are significantly investing in expanding their RWE capabilities.
We’d love to show you how IQVIA Real World Analytics can help you rapidly understand global market landscapes to gain faster insights to improve outcomes.
Tell us a little about your business needs and we'll connect you with a dedicated expert who can share more about our product solutions and answer any questions you have.
Apply real world data to your trial with nonidentified data from more than 500 million patients across eight countries using pre-built analytics.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.